Methylation status of genes escaping from X-chromosome inactivation in patients with X-chromosome rearrangements.


Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 11 03 2021
accepted: 22 06 2021
entrez: 1 7 2021
pubmed: 2 7 2021
medline: 1 2 2022
Statut: epublish

Résumé

X-chromosome inactivation (XCI) is a mechanism in which one of two X chromosomes in females is randomly inactivated in order to compensate for imbalance of gene dosage between sexes. However, about 15% of genes on the inactivated X chromosome (Xi) escape from XCI. The methylation level of the promoter region of the escape gene is lower than that of the inactivated genes. Dxz4 and/or Firre have critical roles for forming the three-dimensional (3D) structure of Xi. In mice, disrupting the 3D structure of Xi by deleting both Dxz4 and Firre genes led to changing of the escape genes list. To estimate the impact for escape genes by X-chromosome rearrangements, including DXZ4 and FIRRE, we examined the methylation status of escape gene promoters in patients with various X-chromosome rearrangements. To detect the breakpoints, we first performed array-based comparative genomic hybridization and whole-genome sequencing in four patients with X-chromosome rearrangements. Subsequently, we conducted array-based methylation analysis and reduced representation bisulfite sequencing in the four patients with X-chromosome rearrangements and controls. Of genes reported as escape genes by gene expression analysis using human hybrid cells in a previous study, 32 genes showed hypomethylation of the promoter region in both male controls and female controls. Three patients with X-chromosome rearrangements had no escape genes with abnormal methylation of the promoter region. One of four patients with the most complicated rearrangements exhibited abnormal methylation in three escape genes. Furthermore, in the patient with the deletion of the FIRRE gene and the duplication of DXZ4, most escape genes remained hypomethylated. X-chromosome rearrangements are unlikely to affect the methylation status of the promoter regions of escape genes, except for a specific case with highly complex rearrangements, including the deletion of the FIRRE gene and the duplication of DXZ4.

Sections du résumé

BACKGROUND
X-chromosome inactivation (XCI) is a mechanism in which one of two X chromosomes in females is randomly inactivated in order to compensate for imbalance of gene dosage between sexes. However, about 15% of genes on the inactivated X chromosome (Xi) escape from XCI. The methylation level of the promoter region of the escape gene is lower than that of the inactivated genes. Dxz4 and/or Firre have critical roles for forming the three-dimensional (3D) structure of Xi. In mice, disrupting the 3D structure of Xi by deleting both Dxz4 and Firre genes led to changing of the escape genes list. To estimate the impact for escape genes by X-chromosome rearrangements, including DXZ4 and FIRRE, we examined the methylation status of escape gene promoters in patients with various X-chromosome rearrangements.
RESULTS
To detect the breakpoints, we first performed array-based comparative genomic hybridization and whole-genome sequencing in four patients with X-chromosome rearrangements. Subsequently, we conducted array-based methylation analysis and reduced representation bisulfite sequencing in the four patients with X-chromosome rearrangements and controls. Of genes reported as escape genes by gene expression analysis using human hybrid cells in a previous study, 32 genes showed hypomethylation of the promoter region in both male controls and female controls. Three patients with X-chromosome rearrangements had no escape genes with abnormal methylation of the promoter region. One of four patients with the most complicated rearrangements exhibited abnormal methylation in three escape genes. Furthermore, in the patient with the deletion of the FIRRE gene and the duplication of DXZ4, most escape genes remained hypomethylated.
CONCLUSION
X-chromosome rearrangements are unlikely to affect the methylation status of the promoter regions of escape genes, except for a specific case with highly complex rearrangements, including the deletion of the FIRRE gene and the duplication of DXZ4.

Identifiants

pubmed: 34193245
doi: 10.1186/s13148-021-01121-6
pii: 10.1186/s13148-021-01121-6
pmc: PMC8244138
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134

Subventions

Organisme : national center for child health and development
ID : 28-6
Organisme : Japan Agency for Medical Research and Development (JP)
ID : 19ek0109373s0202
Organisme : National Center for Child Health and Development
ID : 2019B-4
Organisme : National Center for Child Health and Development
ID : 2019A-1

Références

Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Nat Commun. 2018 Nov 27;9(1):5004
pubmed: 30479398
Genome Biol. 2013 Nov 01;14(11):R122
pubmed: 24176135
Eur J Hum Genet. 2011 May;19(5):507-12
pubmed: 21326285
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
Genome Biol. 2012 Oct 03;13(10):R87
pubmed: 23034086
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Front Cell Dev Biol. 2020 Jan 21;7:328
pubmed: 32076600
Hum Genet. 2011 Aug;130(2):187-201
pubmed: 21597963
Nature. 2005 Mar 17;434(7031):400-4
pubmed: 15772666
Genome Biol Evol. 2018 Sep 1;10(9):2190-2204
pubmed: 30102341
Hum Mol Genet. 2014 Mar 1;23(5):1211-23
pubmed: 24158853
Philos Trans R Soc Lond B Biol Sci. 2017 Nov 5;372(1733):
pubmed: 28947654
J Mol Diagn. 2011 Sep;13(5):537-40
pubmed: 21726665
Genome Biol. 2012 Oct 03;13(10):R92
pubmed: 23034176
Biol Sex Differ. 2015 Dec 30;6:35
pubmed: 26719789
BMC Genomics. 2019 Mar 12;20(1):201
pubmed: 30871455
Front Genet. 2020 Mar 04;11:101
pubmed: 32194616
Am J Med Genet. 1999 Jun 4;84(4):384-5
pubmed: 10340659
Nature. 1961 Apr 22;190:372-3
pubmed: 13764598
Cytogenet Genome Res. 2016;150(2):86-92
pubmed: 28099951
PLoS Genet. 2019 Sep 19;15(9):e1008333
pubmed: 31537017
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
Annu Rev Genet. 1997;31:571-610
pubmed: 9442908
Genome Biol. 2015 Aug 07;16:152
pubmed: 26248554
Bioessays. 2016 Sep;38(9):869-80
pubmed: 27389958
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17055-60
pubmed: 18971342

Auteurs

Sayaka Kawashima (S)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Department of Pediatrics, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, Miyagi, 980-8574, Japan.

Atsushi Hattori (A)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Erina Suzuki (E)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Keiko Matsubara (K)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Machiko Toki (M)

Department of Pediatrics, Hiratsuka City Hospital, 1-19-1 Minamihara, Hiratsuka, Kanagawa, 254-0065, Japan.
Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Rika Kosaki (R)

Division of Medical Genetics, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Yukihiro Hasegawa (Y)

Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan.

Kazuhiko Nakabayashi (K)

Department of Maternal Fetal Biology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Maki Fukami (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.

Masayo Kagami (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. kagami-ms@ncchd.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH